Published in Gene Therapy Weekly, December 18th, 1995
The birth of any child provides the once in a lifetime opportunity to collect autologous cord blood. If the child is born to an HIV infected mother, and is a victim of congenital transmission of this disease, a unique opportunity presents itself to treat the child with a protocol being developed by researchers.
B.R. Davis et al. presented encouraging data at the 37th Annual Meeting of the American Society of Hematology, held December 1-5, 1995, (abstract titled "Genetic Modification of Stem/Progenitor Cells to Protect...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.